Stay updated on AbbVie Press Releases

Sign up to get notified when there's something new on the AbbVie Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the AbbVie Press Releases page

  1. Check
    13 days ago
    Change Detected
    Summary
    Recent updates include AbbVie's European Commission approval of ELAHERE® for treating platinum-resistant ovarian cancer and Allergan Aesthetics offering free online business education courses, while several previous announcements and updates have been removed.
    Difference
    81%
    Check dated 2024-11-23T04:22:44.000Z thumbnail image
  2. Check
    20 days ago
    Change Detected
    Summary
    AbbVie has recently awarded 20 individuals living with migraine to support their career aspirations and provided an update on the Phase 2 results for Emraclidine in schizophrenia, which did not meet its primary endpoint but was well-tolerated.
    Difference
    59%
    Check dated 2024-11-15T22:58:37.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    The website has added news alerts for email subscribers, highlighted the upcoming BOTOX® Cosmetic Day on November 07, 2024, and announced a partnership to develop novel cancer therapies, while removing recent news about SkinSpirit's support for Girls Inc. and the nationwide availability of JUVÉDERM® VOLUMA® XC.
    Difference
    55%
    Check dated 2024-11-08T18:05:14.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    AbbVie has announced a collaboration with EvolveImmune Therapeutics to develop next-generation cancer biotherapeutics and reported strong third-quarter 2024 financial results, raising its full-year guidance and increasing its quarterly dividend.
    Difference
    100%
    Check dated 2024-11-01T10:32:18.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    AbbVie has announced a new collaboration for neuropsychiatric conditions and BOTOX® Cosmetic has received FDA approval for treating vertical bands in the neck, while previous updates on women entrepreneurs and ovarian cancer treatment have been removed.
    Difference
    100%
    Check dated 2024-10-25T00:31:32.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The U.S. FDA has approved VYALEV™ for adults with advanced Parkinson's disease, while Allergan Aesthetics is set to present new data at the 2024 ASDS conference, highlighting advancements in facial aesthetics.
    Difference
    100%
    Check dated 2024-10-17T18:59:25.000Z thumbnail image

Stay in the know with updates to AbbVie Press Releases

Enter your email address, and we'll notify you when there's something new on the AbbVie Press Releases page.